Literature DB >> 14712295

Gene therapy progress and prospects: noninvasive imaging of gene therapy in living subjects.

J J Min1, S S Gambhir.   

Abstract

Recent progress in the development of noninvasive imaging technologies should allow molecular imaging to play a major role in the field of gene therapy. These tools have recently been validated in gene therapy models for continuous quantitative monitoring of the location(s), magnitude, and time variation of gene delivery and/or expression. This article reviews the use of radionuclide, magnetic resonance, and optical imaging technologies, as they have been used in imaging gene delivery and gene expression for gene therapy applications. The studies published to date lend support that noninvasive imaging tools will help to accelerate preclinical model validation, as well as allow for clinical monitoring of human gene therapy.

Entities:  

Mesh:

Year:  2004        PMID: 14712295     DOI: 10.1038/sj.gt.3302191

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  21 in total

1.  Imaging chemically modified adenovirus for targeting tumors expressing integrin alphavbeta3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene.

Authors:  Zhengming Xiong; Zhen Cheng; Xianzhong Zhang; Manish Patel; Joseph C Wu; Sanjiv S Gambhir; Xiaoyuan Chen
Journal:  J Nucl Med       Date:  2006-01       Impact factor: 10.057

Review 2.  Single-photon emission computed tomography in neurotherapeutics.

Authors:  Michael D Devous
Journal:  NeuroRx       Date:  2005-04

Review 3.  Molecular imaging of pulmonary gene expression with positron emission tomography.

Authors:  Sekhar Dharmarajan; Daniel P Schuster
Journal:  Proc Am Thorac Soc       Date:  2005

Review 4.  Noninvasive molecular neuroimaging using reporter genes: part II, experimental, current, and future applications.

Authors:  T F Massoud; A Singh; S S Gambhir
Journal:  AJNR Am J Neuroradiol       Date:  2008-02-13       Impact factor: 3.825

5.  In vivo fluorescence imaging is well-suited for the monitoring of adenovirus directed transgene expression in living organisms.

Authors:  Sevim Kahraman; Ercument Dirice; Ahter Dilsad Sanlioglu; Burcak Yoldas; Huseyin Bagci; Metin Erkilic; Thomas S Griffith; Salih Sanlioglu
Journal:  Mol Imaging Biol       Date:  2009-09-30       Impact factor: 3.488

Review 6.  Gene therapy imaging in patients for oncological applications.

Authors:  Iván Peñuelas; Uwe Haberkorn; Shahriar Yaghoubi; Sanjiv S Gambhir
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12       Impact factor: 9.236

Review 7.  From gene engineering to gene modulation and manipulation: can we prevent or detect gene doping in sports?

Authors:  Giuseppe Fischetto; Stéphane Bermon
Journal:  Sports Med       Date:  2013-10       Impact factor: 11.136

8.  Magnetic resonance imaging of cells in experimental disease models.

Authors:  Naser Muja; Jeff W M Bulte
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2009-07       Impact factor: 9.795

9.  Semiautomated radiosynthesis and biological evaluation of [18F]FEAU: a novel PET imaging agent for HSV1-tk/sr39tk reporter gene expression.

Authors:  Frederick T Chin; Mohammed Namavari; Jelena Levi; Murugesan Subbarayan; Pritha Ray; Xiaoyuan Chen; Sanjiv S Gambhir
Journal:  Mol Imaging Biol       Date:  2007-12-22       Impact factor: 3.488

10.  A new acycloguanosine-specific supermutant of herpes simplex virus type 1 thymidine kinase suitable for PET imaging and suicide gene therapy for potential use in patients treated with pyrimidine-based cytotoxic drugs.

Authors:  Yury Likar; Konstantin Dobrenkov; Malgorzata Olszewska; Elena Vider; Larissa Shenker; Shangde Cai; Nagavarakishore Pillarsetty; Hedvig Hricak; Vladimir Ponomarev
Journal:  J Nucl Med       Date:  2008-04-15       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.